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Abstract: Adenosine analogs in which the sugar unit was replaced by a 1,4-dioxane sugar 
equivalent, were prepared by coupling the 1,4-dioxane sugar analog as its anomeric 
acetates, with N6-benzoyl protected adenine. The 1,4-dioxane system was obtained in an 
enantioselective synthesis from (R,R)-dimethyl tartrate. Using standard phosphorimidite 
methodology, the adenine analog was further reacted with a 1,4-dioxane uridine analog to 
give the corresponding, protected dinucleotide, set-up for further condensation into larger 
oligonucleotides. 
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1. Introduction  
Pursuing development of new antiviral and antitumor agents, a number of new nucleosides analogs 
have been synthesized in which of the sugar structures were modified [1]. The sugar unit has for 
example been replaced by a 1,4-dioxane moiety [2-6]. Some of these structures were reported to 
exhibit interesting biological activities [2,3], which may be ascribed to their particular flexible 
conformational properties [4]. Earlier we reported the synthesis of new optically active uridine analogs 
1a or 1b where the sugar was substituted by an optically active 1,4-dioxane moiety [7]. These uridine 
analog was further elaborated into the corresponding dinucleotide using standard phosphorimidite 
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methodology [8]. However, we also reported [7] that preparation of the related adenosine analog 
failed. In this communication we wish to report our recent findings dealing with the synthesis of 
adenosine analogs 2a and 2b, which as the N-benzoyl protected compounds were then tested in 
dinucleotide formation with uridines 1a. 
Figure 1. Uridine and adenosine analogs containing a 1,4-dioxane sugar equivalent. 
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2. Results and Discussion  
The synthesis of 1,4-dioxane sugar analog 3 from (2R,3R)-dimethyl tartrate was reported earlier [7]. 
The tartrate was first converted into the corresponding enantiomerically pure diethyl (2R,3R)-2-O-
allyltartrate either by the reaction with allyl bromide in the presence of silver oxide or in a tin assisted 
reaction with dibutyltin oxide [9-11]. The allyl ether was reduced by LiAlH4 [12-14] or NaBH4 [15,16] 
to give a triol which was protected as an acetal with 2,2-dimethoxy-propane in the presence of  
p-toluene sulfonic acid. Subsequent ozonolysis afforded 1,4-dioxane sugar analog 3 which was further 
transformed into acetate 4 with acetic anhydride (Scheme 1). All the tartrate stereoisomers are readily 
available from the chiral pool, conveniently allowing for the synthesis of all the possible stereoisomers 
of the nucleoside analogs. 
Scheme 1. Synthesis of 1,4-dioxane sugar analogs 3 and 4 [7]. 
 
 
2.1. Synthesis of Adenosine Analogs 
 
The corresponding adenine nucleoside analog from 4 was attempted prepared using a Vorbrüggen 
procedure [17,18]. Thus, acetate 4 was coupled with silylated adenine 5, in the presence of 
trimethylsilyl trifluoromethanesulfonate (TMSOTf) to give 6 as a cis/trans mixture in 23% yield after 
flash chromatography. However, HMBC-NMR spectroscopic analysis showed that the product was the 
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undesired N-7 regioisomer 6, as three bond correlations were observed for the anomeric proton with C5 
as well as C8 (Scheme 2).  
Scheme 2. Synthesis of N-7 adenine nucleoside analogs 6. 
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For reasons of forcing the adenine to react at the 9-position, 4 was instead reacted with the silylated 
N6-benzoyl protected adenine, 7, in the presence of TMSOTf, affording the desired  benzoyl protected 
adenine nucleoside analogues 8 as a cis/trans mixture in 42 % isolated yield after chromatographic 
purification, Scheme 3. The structure was confirmed by NMR analysis.  
Scheme 3. Synthesis of benzoyl adenine nucleoside analogues 8. 
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Attempts to remove the acetal protection group in 8 failed, as depurination was observed to take 
place in all cases. A number of literature methods described were tested [19,20], such as cleavage 
using 80% acetic acid [21] or CSA as catalyst, reaction with Amberlyst 15, HCl [22] or trifluoroacetic 
acid [23]. Other reagents, such as ferric chloride on silica gel [24], iodine in methanol [25] or alumina 
or silica gel catalysis in all cases gave no or similar results. The desired benzoyl protected nucleoside 
analog 9 was finally obtained by the reaction sequence shown in Scheme 4.  
Scheme 4. Synthesis of benzoyl protected adenine nucleoside analogue 9.  
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Conversion of 3 to the corresponding triacetate 10 by the reaction with acetic anhydride in the 
presence of catalytic amount of H2SO4 [26,27] gave the desired product though in a poor yield. 
Product 10 was, however, obtained in a satisfactory yield when 3 were reacted with acetic anhydride in 
the presence of 1.1 equivalent of p-TsOH [28]. Subsequently the triacetate was smoothly coupled with 
the silylated benzoyl adenine 7 in the presence of TMSOTf to afford benzoyl adenine nucleoside 
analogue 11. The acetate groups were selectively removed by ammonia in methanol [29] leaving the 
desired, benzoyl-protected nucleoside analog 9 (Scheme 4).  
 
2.2. Synthesis of Dinucleotide Analogs 
 
The pure trans-nucleoside analog 9a was separated by flash chromatography from the mixture of 
diastereomers of compound 9. Treatment of 9a with 4,4'-dimethoxyltrityl chloride (DMTrCl) in 
pyridine [30] afforded the primary hydroxyl group protected compound 12a in 40% yield after flash 
chromatography. Compound 12a was next reacted with N,N-diisopropyl-2-cyanoethylphosphor-amidic 
chloride [31,32] in the presence of N,N-diisopropylethylamine to give the desired phosphoramidite 13a 
in 51% isolated yield, Scheme 5. 
Scheme 5. Synthesis of phosphoramidite 13a. 
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We have previously reported the synthesis of the uridine analog 1, obtained from acetates 4. The 
trans-anomer 1a was isolated in 42% yield after recrystallization from acetonitrile, and subsequently 
converted to the secondary acetate 14a [7]. 
Figure 2. Trans-uridine analogs 1a and 14a. 
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The coupling of adenosine phosphoramidite 13a with uridine analog 14a was carried out in the 
presence of 1H-tetrazole in dry acetonitrile [33], followed by iodine oxidation and purification by flash 
chromatography on silica gel. This afforded the uracil adenine dinucleotide analog 15 in 62% yield, 
Scheme 6. To obtain the analytically pure dinucleotide 15, the product was purified by multi elution 
preparative TLC. 
Scheme 6. Synthesis of 1,4-dioxane uracil adenine dinucleotide analog 15. 
 
 
Further elaboration of product 15 was not pursued, as it at this stage was demonstrated that the  
1,4-dioxane nucleoside analogs can function in the standard reaction scheme for oligonucleotide 
preparations, used in for example automatic nucleotide synthesis machines. Thus 15 represent a 
standard intermediate for the further preparation of oligonucleotides. 
3. Experimental  
3.1. General 
 
NMR spectra were recorded on Bruker Avance DPX 300 or DPX 400 instruments. Chemical shifts 
are reported in ppm using TMS (d = 0.0) as the internal standard in CDCl3 or relative to 2.50 ppm for 
1H and 39.99 ppm for 13C in [d6-DMSO] or 3.31 ppm for 1H and 49.15 ppm for 13C in CD3OD. 
Structural assignments were based on 1H, 13C, DEPT135 and 2D-spetra, COSY, HSQC, HMBC, and 
NOESY. EI-Mass and ESI spectra were recorded on a Finnigan MAT 95XL spectrometer. IR spectra 
were obtained on a Thermo Nicolet FT-IR Nexus spectrometer using a Smart Endurance reflection 
cell. For ozonolysis was used an OZ-500 Ozone Generator produced by Fishcer Technology. Silica gel 
Kieselgel 60G (Merck) was used for Flash Chromatography. The solvents were purified by standard 
methods. All reactions were carried out in inert atmospheres (nitrogen). The synthesis of compounds 
1a and 14a has been described elsewhere [7]. 
 
(2S,5S)-5-[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2-acetyloxy-1,4-dioxane (4a) and (2R,5S)-5-[(4S)-
2,2-dimethyl-1,3-dioxolan-4-yl]-2-acetyloxy-1,4-dioxane (4b). To a solution of 3 (1.0 g, 4.9 mmol) in  
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dry pyridine (15 mL) was added acetic anhydride (0.62 g, 6 mmol) at 0–5 °C and the reaction mixture 
was stirred for 6 hours. The solution was concentrated under reduced in vacuo overnight, yielding the 
crude product in 87% yield as an oily solid material, which was used in the subsequent reaction step 
without further purification. The anomeric ratio 4a:4b (trans-cis ratio) was determined to be 4:1 by 
NMR. The products exhibited the following spectroscopic properties: The trans-product 4a (Figure 1) 
was assigned the following signals: 1H-NMR (CDCl3, 400 MHz): δ 1.36, 1.43 (s, 2 × 3H, (CH3)2C), 
2.11 (s, 3H, CH3COO), 3.48 (dd, J = 8.0 Hz, 11.4 Hz, 1H, HB1), 3.63 (m, 1H, HC), 3.69 (dd,  
J = 9.4 Hz, 11.4 Hz, 1H, HD1), 3.81 (dd, J = 6.8 Hz, 8.0 Hz, 1H, (CH3)2C-O-CH2), 3.89 (dd,  
J = 2.6 Hz, 11.4 Hz, 1H, HD2), 3.93 (dd, J = 2.8 Hz, 11.4 Hz, 1H, HB2), 4.00 (dd, J = 6.8 Hz, 8.4 Hz, 
1H, (CH3)2C-O-CH2), 4.15 (m, 1H, (CH3)2C-O-CH-), 5.74 (dd, J = 2.8 Hz, 8.4 Hz, 1H, HA) ppm.  
13C-NMR (CDCl3, 100 MHz): δ 20.9, 25.2, 26.3, 65.2, 65.6, 66.9, 74.2, 74.2, 89.4, 109.7, 169.0 ppm. 
The protons NMR spectrum of the corresponding cis- compound, 4b, could not be fully assigned due 
to the peaks overlap with 4a, however, the carbon NMR spectrum of the cis- compound was assigned 
the following signals: 13C-NMR (CDCl3, 100 MHz): δ 21.1, 25.2, 26.2, 61.0, 64.9, 67.6, 74.9, 75.1, 
88.4, 109.7, 169.8 ppm. The mixture exhibited the following mass spectrum: MS (EI) m/z: 247 
(M++1), 231(M+-CH3), 187(M+-OAc), 145 (C6H9O4). Elem. Anal. calcd. for C11H18O6: C 53.65,  
H 7.37; found C, 53.84, H 7.45. 
Figure 1. Structure of compound 4a. 
 
 
 
 
 
 
N-7-{(2R,5S)-5-[(4S)-(2,2-Dimethyl-1,3-dioxolan-4-yl)]-1,4-dioxan-2-yl}adenine (6a) and N-7-
{(2S,5S)-5-[(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)]-1,4-dioxan-2-yl}adenine (6b). The mixture of 
adenine (1.35 g, 10 mmol) and ammonium sulfate (124 mg, 0.9 mmol) in hexamethyldisilazane 
(HMDS, 35 mL) was refluxed overnight. The solvent was evaporated and the residue was dissolved in 
dry dichloroethane (20 mL). To this solution, compound 4 (0.85 g, 3.5 mmol) was added. The solution 
was cooled to 0 °C and TMSOTf (0.75 mL, 4 mmol) was added. The solution was stirred for 8 hours at 
room temperature. The chloroform (50 mL) was added and the solution was washed twice with 
saturated NaHCO3 solution (15 mL). The aqueous phase was extracted twice with chloroform (50 mL), 
and the combined organic layers was dried over anhydrous MgSO4 and filtered and concentrated under 
reduced pressure. The residue was purified by flash chromatography using a mixture of 
dichloromethane and methanol (19:1) as the eluent. A white solid (0.26 g, 23%) was obtained which 
was identified as a 3:2 mixture of the trans- and cis- products 6a and 6b. From the mixture of isomers 
was extracted the following spectroscopic properties for isomer 6a (Figure 2): 1H-NMR (CDCl3,  
400 MHz): δ 1.47, 1.48 (s, 2 × 3H, HI), 3.87–3.91 (m, 3H, HB), 3.97–4.03 (m, 3H, HA and HE), 4.04 
(dd, J = 12 Hz, 6 Hz, 1H, HD2), 4.07 (dd, J = 8.4 Hz, 6.8 Hz, 1H, HA), 4.21–4.27 (m, 2H, HC and HD), 
O
O
HC
HD2
HD1
HAHB1
HB2
OCOCH3
O
HB
4a
O
Molecules 2011, 16                            
 
 
3991
5.72 (dd, J = 8.8 Hz, 4 Hz, HF), 5.99 (br.s, 2H, NH2), 8.11 (s, 1H, HG), 8.54 (s, 1H, HH) ppm.  
13C-NMR (CDCl3, 100 MHz): δ 25.2, 26.4, 66.1, 68.5, 60.4, 74.1, 82.0, 110.3, 111.1, 144.0, 151.3, 
154.0, 161.6 ppm. For the mixture of 6a and 6b:  IR (neat): 3418, 3290, 3149, 2979, 2905, 1625, 1595, 
1062 cm-1. HRMS (ESI): Calcd. for C14H19N5O4 [M+Na]+ 322.1516, Found 322.1513. 
Figure 2. Structure of compound 6a. 
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N-6-Benzoyl-N-9-{(2R,5S)-5-[(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)]-1,4-dioxan-2-yl} adenine (8a) 
and N-6-benzoyl-N-9-{(2S,5S)-5-[(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)]-1,4-dioxan-2-yl}-adenine 
(8b). N6-benzoyladenine (2.065 g, 8.7 mmol) and ammonium sulfate (120 mg, 0.9 mmol) in HMDS 
(50 mL) was refluxed overnight. The solution was cooled and concentrated under reduced pressure. 
The residue was dissolved in dry acetonitrile (20 mL) and added a solution of 6 (0.77 g, 3.1 mmol) in 
dry acetonitrile (5 mL). The mixture was then cooled to 0 °C and added TMSOTf (0.6 mL, 3.3 mmol). 
The mixture was stirred for four hours. Then chloroform (50 mL) was added and the solution washed 
twice with saturated NaHCO3 solution (20 mL). The organic phase was dried over anhydrous MgSO4 
filtered and concentrated under reduced pressure. The crude product was purified by flash 
chromatography using a gradient eluent system, first diethyl ether, followed by a mixture of 
dichloromethane and methanol (19:1) to afford the product as a yellow solid (0.55 g, 42%) as a 3:1 
mixture of trans- and cis products 8a and 8b. Pure 8a was obtained by repeated chromatography. 
Product 8a (Figure 3) exhibited the following spectroscopic properties: 1H-NMR (CDCl3, 400 MHz):  
δ 1.41, 1.52 (s, 2 × 3H, HG), 3.48 (dd, J = 11.4 Hz, 9.4 Hz, 1H, HE2), 3.79–3.84 (m, 1H, HC), 3.94–3.97 
(m, 1H, HA), 4.00 (dd, J = 11.6 Hz, 10.8 Hz, 1H, HD1), 4.09 (dd, J = 8.4 Hz, 6.8 Hz, 1H, HA), 4.17 (dd, 
J = 11.6 Hz, 2.6 Hz, 1H, HD2), 4.20–4.25 (m, 1H, HB), 4.54 (dd, J = 11.4 Hz, 2.6 Hz, HE1), 6.64 (dd,  
J = 9.2 Hz, 2.8 Hz, 1H, HF), 7.43–7.49 (m, 2H, HK), 7.50–7.54 (m, 1H, HL), 8.23–8.28 (m, 2H, HJ) 
ppm. 13C-NMR (CDCl3, 100 MHz): δ 25.4, 26.4, 62.8, 65.0, 66.6, 74.1, 74.4, 81.9, 110.3, 115.2, 
128.4, 130.1, 132.4, 137.5, 142.1, 144.9, 149.3, 157.2, 175.6 ppm. For the mixture of 8a and 8b: IR 
(neat): 3214, 2985, 1635, 1597, 1480, 1116, 1067, 1048 cm−1. HRMS (ESI): Calcd. for C21H23N5O5 
[M+H]+ 426.1778, Found 426.1776.  
Figure 3. Structure of compound 8a. 
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(2R,5S)-5-[(1S)-(1,2-Diacetyloxy)]-2-acetyloxy-1,4-dioxane (10a) and (2S,5S)-5-[(1S)-(1,2-diacetyl-
oxy)]-2-acetyloxy-1,4-dioxane (10b). Compound 3 (2.2 g, 10.8 mmol) and p-TsOH (2.26 g,  
11.9 mmol) was dissolved in acetic anhydride (50 mL). The mixture was stirred for 7 hours at room 
temperature and then poured into ice water. To the mixture was neutralized with sodium bicarbonate, 
and then extracted with ethyl acetate. The organic phase was dried over anhydrous MgSO4 filtration 
and evaporated under reduced pressure. The residue was purified by flash chromatography using a 
mixture of diethyl ether and n-hexane (2:1) as the eluent. The product appeared as yellow oil, (2.35 g, 
75%). The diastereomers were not separated, however the NMR of the one diastereomer (Figure 4) 
was assigned the NMR signals: 1H-NMR (CDCl3, 400 MHz): δ 2.07, 2.14, 2.15 (s, 3 × 3H, CH3), 
3.59–3.61(m, 1H, HD), 3.83 (dd, J = 12.8 Hz, 2H, 1H, HE), 3.89–3.98 (m, 3H, HE, HD and HC), 4.16 
(dd, J = 12 Hz, 6.8 Hz, 1H, HA), 4.36 (dd, J = 11.8 Hz, 4.2 Hz, 1H, HA), 5.15–5.18 (m, 1H, HB), 5.87 
(d, 2Hz, 1H, HF) ppm. 13C-NMR (CDCl3, 100 MHz): δ 20.7, 20.8, 21.1, 61.2, 62.1, 68.1, 69.8, 73.6, 
88.2, 169.8, 170.2, 170.5 ppm. The NMR data for the other diastereomer were the following: 1H-NMR 
(CDCl3, 400 MHz): δ 2.10, 2.11, 2.16 (s, 3 × 3H, CH3), 3.78–3.82(m, 1H, HC), 3.83 (dd, 12.8Hz, 2Hz, 
1H, HE), 3.93 (d, 12.8Hz, 1H, HE), 4.13–4.26 (m, 5H, HB, HD and HA), 5.87 (d, 2Hz, 1H, HF) ppm.  
13C-NMR (CDCl3, 100 MHz): δ 20.7, 20.8, 21.4, 63.1, 63.4, 67.6, 68.8, 74.2, 89.0, 169.7, 170.5, 170.6 
ppm. IR (neat): 2959, 1737, 1219, 1044, 1014 cm−1. MS (m/z): 289.3, 243.3, 231.3, 217.3.  
Figure 4. Structure of compound 10. 
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N-6-Benzoyl-N-9-{(2R,5S)-5-[(1S)-(1,2-diacetyloxy)]-1,4-dioxan-2-yl}adenine (11a) and N-6-benzoyl-
N-9-{(2S,5S)-5-[(1S)-(1,2-diacetyloxy)]-1,4-dioxan-2-yl}adenine (11b). N-6-benzoyladenine (1.09 g, 
4.6 mmol) and ammonium sulfate (62 mg, 0.47 mmol) in HMDS (50 mL) was refluxed overnight. The 
mixture containing the silylated N-6-benzoyladenine 7 was concentrated under reduced pressure, 
dissolved in dry dichloroethane (24 mL) and then added a solution of 10 (0.74 g, 2.6 mmol) in dry 
dichloromethane (6 mL). This mixture was added TMSOTf (0.94 mL, 5.2 mmol) at 0 °C and stirred 
overnight at room temperature. Chloroform (50 mL) was added to the mixture which was washed with 
saturated NaHCO3 solution (25 mL). The aqueous phase was extracted with chloroform (50 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and filtered and concentrated under 
reduced pressure. The residue was purified by flash chromatography using a mixture of 
dichloromethane and methanol (9/1) as the eluent to afford the product (0.67 g, 56%) as a mixture of 
the trans and cis products, 11a and 11b. The product was used for the next reaction without further 
purification. The NMR was too complex to allow reasonable assignments of the signals. IR (neat): 
2958, 1737, 1636, 1216.1045, 1023 cm−1. HRMS (ESI): Calcd. for C22H23N5O7 [M+H]+ 470.1677, 
Found 470.1663.  
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N-6-Benzoyl-N-9-{(2R,5S)-5-[(1S)-(1,2-dihydroxyl)]-1,4-dioxan-2-yl}adenine (9a) and N-6-benzoyl-N-
9-{(2S,5S)-5-[(1S)-(1,2-dihydroxyl)]-1,4-dioxan-2-yl}adenine (9b). Compound 11 (1.27 g, 30 mL) was 
dissolved in 7N ammonia in methanol (30 mL) and stirred for 7 hours at room temperature. The 
solution was concentrated and purified by flash chromatography using a mixture of dichloromethane 
and methanol (19/1) as the eluent. The pure trans- product 9a was isolated (140 mg, 13.5%, Figure 5). 
Product 9a exhibited the following spectroscopic properties: 1H-NMR (CD3OD, 400 MHz): δ 3.59 (dd,  
J = 11.2 Hz, 9.4 Hz, 1H, HE2), 3.60–3.70 (m, 3H, HA and HB), 3.89 (dt, J = 10.6 Hz, 2.8 Hz, 1H, HC), 
4.13 (dd, J = 11.8, 10.6 Hz, 1H, HD1), 4.24 (dd, J = 11.8, 2.8 Hz, 1H, HD2), 4.37 (dd, J = 11.2 Hz,  
2.6 Hz, 1H, HE1), 6.55 (dd, J = 9.4, 2.6 Hz, 1H, HF), 7.41–7.45 (m, 1H, HI), 7.49–7.53 (m, 2H, HK), 
8.21–8.24 (m, 1H, HC), 8.24 (s, 1H, HG), 8.67 (s, 1H, HH) ppm. 13C-NMR (CD3OD, 100 MHz): δ 63.8, 
70.4, 70.8, 72.1, 76.3, 82.6, 115.5, 129.3, 131.0, 133.4, 138.2, 144.2, 145.2, 149.7, 156.9, 176.6ppm. 
IR (neat): 3286, 2876, 1635, 1424, 1285, 1115, 1063, 1021cm-1. HRMS (ESI): Calcd. for C18H19N5O5 
[M+H]+ 470.1677, Found 470.1668.  
Figure 5. Structure of compound 9a. 
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N-6-Benzoyl-N-9-{(2S,5S)-5-[(1S)-hydroxyl-2-O-(4,4-dimethoxytrityl)-ethyl-1-yl]-1,4-dioxan-2-yl}-
adenine (12). Compound 9 (mixture of 9a and 9b, 139 mg, 0.36 mmol) and dimethoxyltrityl chloride 
(277 mg, 0.79 mmol) were dissolved in dry pyridine (10 mL). The solution was stirred at room 
temperature for 3 hours. The solution was concentrated in vacuo and residue was purified by flash 
chromatography using first diethyl ether and then ethyl acetate as the eluent to provide the product 
(12a and 12b) as a white solid (100 mg, 40%). Product 12a (Figure 6) was obtained upon repeated 
chromatography and exhibited the following spectroscopic properties: 1H-NMR (CDCl3, 400 MHz): δ 
2.82 (d, J = 4.8 Hz, 1H, OH), 3.25 (dd, J = 9.6 Hz, 5.4 Hz, 1H, HA), 3.34 (dd, J = 9.6 Hz, 5.6 Hz, HA), 
3.43 (dd, J = 11.2 Hz, 9.2 Hz, HE2), 3.75–3.82 (m, 1H, HB), 3.77 (s, 2 × 3H, OCH3), 3.86–3.90 (m, 1H, 
HC), 4.00 (dd, J = 12 Hz, 10.2 Hz, HD1), 4.13 (dd, J = 12 Hz, 2.8 Hz, HD2), 4.43 (dd, J = 11.2 Hz,  
2.8 Hz, HE), 6.60 (dd, J = 9.2 Hz, 2.8 Hz, HF), 6.82–6.86 (m, 5H, aromatic protons), 7.20–7.24 (m, 1H, 
aromatic proton), 7.26–7.37 (m, 5H, aromatic protons), 7.40–7.53 (m, 5H, aromatic protons), 8.13 (s, 
1H, HG), 8.15–8.25 (m, 2H, aromatic protons), 8.64 (s, 1H, HH) ppm. 13C-NMR (CDCl3, 100 MHz): δ 
55.2, 63.8, 69.3, 69.4, 70.0, 75.5, 81.0, 86.5, 113.2, 126.9, 129.8, 130.0, 132.3, 135.7, 135.8, 137.1, 
142.1, 143.0, 144.6, 148.4, 157.1, 158.6, 175.4 ppm. HRMS (ESI): Calcd. for C39H37N5O7 [M+Na]+ 
710.2591, Found 710.2588. 
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Figure 6. Structure of compound 12a. 
 
 
 
 
 
 
 
 
 
N-6-Benzoyl-N-9-{(2S,5S)-5-{(1S)-O-[2-cyanoethoxy(diisopropylamino)phosphino]-2-O-(4,4′-di-
methoxytrityl)-ethyl-1-yl}-1,4-dioxan-2-yl}adenine (13a). Compound 12 (mixture of 12a and 12b)  
(99 mg, 0.14 mmol) was dissolved in dry dicholormethane (6 mL) was then added N,N-diisopropyl-
ethylamine (50 µL, 0.29 mmol). Then N,N-diisopropyl-2-cyanoethyl phosphoramidic chloride  
(105 µL, 0.47 mmol) was added. The resulting solution was stirred for 6 hours at room temperature. 
The solution was then concentrated and purified by flash chromatography using a mixture of ethyl 
acetate and n-hexane (4:1) as the eluent to give the trans isomer 13a (65 mg, 51%) as a mixture of 
diastereomers due to the stereogenic phosphorus. Major diastereomer 13a (Figure 7) had the following 
spectroscopic properties: 1H-NMR (CDCl3, 400 MHz): δ 1.14 (d, J = 7.2 Hz, 2 × 3H, HK), 1.19 (d,  
J = 7.2 Hz, 2 × 3H, HK), 2.64 (dt, J = 6.4, 2.4 Hz, 2H, HI), 3.27 (dd, J = 9.4, 5.2 Hz, 1H, HA), 3.36 (dd,  
J = 9.4, 6 Hz, 1H, HA), 3.45 (dd, J = 11.2, 9.4 Hz, 1H, HE2), 3.56–3.70 (m, 2 × 1H, HL), 3.771, 3.768 
(s, 2 × 3H, OCH3), 3.72–3.82 (m, 1H, HJ), 3.87–3.95 (m, 1H, HJ), 4.00–4.09 (m, 3 × 1H, HB, HD, HC), 
4.24 (d, J = 10 Hz, 1H, HD), 4.40 (dd, J = 11.2, 2.6 Hz, 1H, HE1), 6.61 (dd, J = 9.4, 2.6 Hz, 1H, HF), 
6.81–6.85 (m, 4H, aromatic H), 7.19–7.22 (m, 1H, aromatic H), 7.27–7.30 (m, 2H, aromatic H),  
7.34–7.36 (m, 4H, aromatic H), 7.41–7.48 (m, 4H, aromatic H), 7.52–7.56 (m, 4H, aromatic H), 8.14 
(s, 1H, HG), 8.22–8.25 (m, 2H, aromatic H), 8.69 (s, 1H, HH), 12.59 (s, 1H, NH) ppm. 13C-NMR 
(CDCl3, 100 MHz): δ 20.4, 20.5, 24.56, 24.64, 24.67, 24.74, 43.2, 43.4, 55.2, 58.0, 58.2, 60.4 ,69.55, 
69.62, 72.1, 75.3, 75.4, 81.3, 86.4, 113.1, 114.4, 117.7, 126.8, 127.8, 128.2, 128.3, 129.9, 130.05, 
130.09, 132.3, 135.95, 136.01, 137.2, 141.8, 143.3, 144.8, 148.4, 157.2, 158.5, 175.5 ppm. 31P-NMR 
(CDCl3): 151.0, 152.0 (small) ppm. IR (neat): 3239, 3056, 2965, 2929, 2362, 2338, 1637, 1507, 1251, 
1083, 788, 754, 719 cm−1. HRMS (ESI): Calcd. for C48H54N7O8P [M+Na]+ 910.3669, Found 910.3639. 
Figure 7. Structure of compound 13a. 
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1-[(2R,5S)-5-[(1S)-Acetyloxy-2-hydroxylethyl-1-yl]-1,4-dioxan-2-yl]uracil (14a). The synthesis of this 
compound has been reported earlier [7]. Compound 14a (Figure 8) exhibited the following 
spectroscopic properties: 1H-NMR (CD3OD, 400 MHz): δ 2.07 (s, 3H, CH3), 3.58 (dd, J = 11.4 Hz, 
9.8Hz, 1H, HE2), 3.70–3.74 (m, 1H, HB), 3.77–3.82 (m, 1H, HC), 3.92–3.98 (m, 2H, HE and HD1), 4.06 
(dd, J = 11.6, 2.8 Hz, 1H, HD2), 4.13 (dd, J = 11.2, 6.4 Hz, 1H, HA), 4.16 (dd, J = 11.2 Hz, 5.4Hz, 1H, 
HA), 5.69 (dd, J = 10 Hz, 2.8 Hz, 1H, HF), 5.70 (d, J = 8 Hz, 1H, HH), 7.71 (d, J = 8 Hz, 1H, HG) ppm. 
13C-NMR (CD3OD, 100 MHz): δ 20.9, 66.4, 69.2, 69.4, 69.8, 76.0, 80.0, 103.1, 142.3, 151.9, 166.0, 
172.8 ppm. IR (neat): 3477, 3190, 3110, 3074, 2996, 2879, 1697, 1268, 1105 cm−1. MS (EI): 230.3, 
197(M+-(CH3COCHCH2OH)), 189(M+-uracil). HRMS (ESI): Calcd. for C12H16N2O7 [M+Na]+ 
323.0856, Found 323.0862. 
Figure 8. Structure of compound 14. 
 
 
N6-Benzoyladenine uracil dinucleotide (15). Compound 13a (30 mg, 0.039 mmol) and 14a (8 mg, 
0.027 mmol) in a reaction flask with a magnetic stirring bar were dried under high vacuum for 4 hours. 
Then a mixture 1-H tetrazole (0.3 mL, 0.45 M, 0.135 mmol) in dry acetonitrile (6 mL) was added 
under a nitrogen atmosphere. The solution was stirred overnight at room temperature. Then was added 
a few drops of iodine in THF (1M solution), 2,6-lutidine and H2O (2:2:1) until an orange color 
persisted. The solution was then quenched with saturated sodium thiosulfate solution (4 mL). Then the 
two phases were treated with saturated NaHCO3 solution (4 mL). The separated aqueous phase was 
extracted with 4 × 8 mL of dichloromethane. The combined organic phase was dried over anhydrous 
Na2SO4 and filtered and the solvent evaporated. Flash chromatographic purification, using mixtures of 
dichloromethane and methanol in the ratio from 25:1 to 15:1 as gradient solvents, afforded a product 
(16 mg, 61.5%), which was assigned structure 15 (Figure 9) based on the following spectroscopic 
properties: 1H-NMR (CDCl3, 400 MHz): δ 2.02 (s, 3H, CH3COO), 2.09 (s, 3H, CH3COO), 2.51–2.62 
(m, 2H, CH2CN), 2.71–2.74 (m, 2H, CH2CN), 3.15 (dd, 1H, J = 11.2 Hz, 9.6Hz), 3.21–3.28 (m), 3.38 
(dd, J = 11.4 Hz, 9.8Hz), 3.45–3.58 (m), 3.62–3.96 (m), 4.01 (dd, 1H, J = 11.2 Hz, 2.8Hz), 4.03–4.13 
(m), 4.14–4.35 (m), 4.37–4.47 (m), 4.63–4.74 (m), 5.58 (dd, 1H, J = 9.8 Hz, 3 Hz, anomeric proton), 
5.66–5.71 (m, 3H, two protons in uracil and one anomeric proton), 6.62–6.68 (m), 6.84–6.89  
(m, aromatic protons), 7.20 (d, J = 8 Hz, 1H, a proton in uracil), 7.22–7.28 (m, aromatic protons),  
7.30–7.37 (m, aromatic protons and one proton in uracil), 7.42–7.49 (m, aromatic protons), 7.52–7.58 
(m, aromatic protons), 8.143 (s, 1H, a proton in adenine), 8.148 (s, 1H, a proton in adenine), 8.23–8.25 
(m, aromatic protons), 8.33 (br. 1H, NH), 8.63 (s, a proton in adenine), 8.64 (s, a proton in adenine) 
ppm. 13C-NMR (CDCl3, 100 MHz): δ 20.76, 20.82, 55.3, 62.0–62.5 (m), 67.6, 68.1, 68.4, 69.4, 73.2, 
74.4, 74.8, 78.4, 78.5, 80.9, 86.8, 86.9, 102.7, 102.8, 128.06, 128.10, 128.3, 129.9, 130.0, 132.4, 
134.98, 135.02, 135.2, 137.1, 139.2, 139.3, 141.9, 142.9, 148.4, 149.5, 157.2, 158.8, 162.1, 170.4, 
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175.6 ppm. 31P-NMR (CDCl3): −1.28, −1.49 ppm. HRMS (ESI): Calcd. for C54H55N8O16P [M+Na]+ 
1125.3372, Found 1125.3354. 
Figure 9. Structure of compound 15. 
 
4. Conclusions 
The synthesis of the adenosine analogs containing an optically active 1,4-dioxane sugar equivalent 
was achieved by coupling of N-silylated N-6-benzoyl protected adenine with the sugar acetate 
equivalents. Applying conventional phosphorimidite methodology the adenine analog was further 
coupled to the related uridine analog to give the corresponding protected dinucleotide, thus making it 
feasible that larger oligonucleotides can be prepared, including the application of conventional 
automated procedures. 
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